TBE (Tick-borne encephalitis virus) IgG antibodies
Specific IgG antibodies are produced in response to contact with the tick-borne encephalitis (TBE) virus.

ClinicLab
- Test description
Specific IgG antibodies are identified as being produced in response to contact with the tick-borne encephalitis (TBE) virus.
When to Perform the Test
Specific IgG antibodies are produced by the immune system in response to contact with the TBE virus, which can be contracted through a tick bite. These antibodies play a key role in combating the infection and in creating long-term immunity against the TBE virus. Early detection of IgG antibodies in the blood indicates a past or ongoing infection, and their presence may suggest immunity following infection or vaccination against TBE.
Serological tests enable the identification of these antibodies, which is essential for diagnosis and monitoring immunity.
Medical Conditions
Tick-borne encephalitis (TBE) is a disease of the central nervous system.
In the natural environment, the TBE virus is carried by wild, farm, and domestic animals. Although the virus does not cause illness in these animals, it poses a risk to humans. Ticks act as vectors for TBE – once infected with the virus, they remain carriers for life. The most common route of human infection is a bite from an infected tick, which represents the primary risk of virus transmission.
Symptoms
Symptoms of TBE virus infection include fever, limb muscle pain, nausea and vomiting, altered consciousness, photophobia, headaches, and dizziness.